Phoenix Biotech Acquisition Corp.
Phoenix Biotech Acquisition Corp. (PBAX) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
pbax · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Phoenix Biotech Acquisition Corp. (PBAX) measures how much investors pay for each dollar of the company's trailing earnings. PBAX's current PE ratio of N/A is calculated by dividing its stock price of $5.85 by its TTM earnings per share of -$3.34.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2021 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Shell Companies · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Phoenix Biotech Acquisition Corp.You PBAX | $36M | N/A | — | -$3.34 |
 A SPAC I Acquisition Corp. ASCA | $33M | N/A | — | -$0.13 |
 Achari Ventures Holdings Corp. I AVHI | $31M | N/A | — | -$0.77 |
 Blue Safari Group Acquisition Corp. BSGA | $35M | N/A | — | -$0.55 |
 ConnectM Technology Solutions, Inc. CNTM | $16M | N/A | — | -$7.19 |
 Gardiner Healthcare Acquisitions Corp. GDNR | $41M | 246.14x | +82.4% | $0.04 |
 Iron Horse Acquisitions Corp. Common Stock IROH | $36M | 23.75x | -82.4% | $0.17 |
Industry Average 2 peers with valid PE | — | 134.95x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-22.58 | — | |
2024-12-31 FY2024 | — | $-0.22 | — | |
2022-12-31 FY2022 | — | $-0.01 | — | |
2021-12-31 FY2021 | — | $-0.00 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Phoenix Biotech Acquisition Corp. (PBAX) measures how much investors pay for each dollar of the company's trailing earnings. PBAX's current PE ratio of N/A is calculated by dividing its stock price of $5.85 by its TTM earnings per share of -$3.34.
Frequently asked questions
PBAX pe ratio · 6 questionsPBAX's current PE ratio is N/A as of 2026-06-09, based on a stock price of $5.85 and TTM EPS of -$3.34. Data sourced from Financial Modeling Prep via PBAX's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Phoenix Biotech Acquisition Corp. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09